Finance

Lists
Why is XSPRAY up 10.28%?
Dive Deeper
XSPRAY:STO
Xspray Pharma publ AB
SEK 11.80
+10.28%
(+1.10) 1D
Oct 30, 5:00:00 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for XSPRAY...
Open
SEK 10.88
High
SEK 11.80
Low
SEK 10.76
Mkt. cap
559.52M
Avg. vol.
72.41K
Volume
65.23K
52-wk high
SEK 35.15
52-wk low
SEK 9.06
EPS
-SEK 3.79
Shares outstanding
47.42M
No. of employees
24
Open
SEK 10.88
High
SEK 11.80
Low
SEK 10.76
Mkt. cap
559.52M
Avg. vol.
72.41K
Volume
65.23K
52-wk high
SEK 35.15
52-wk low
SEK 9.06
EPS
-SEK 3.79
Shares outstanding
47.42M
No. of employees
24
News stories
From web sources and news partners
About Xspray Pharma publ AB
CEOPer Andersson
Employees24
Founded2003
Headquarters-
SectorBiotechnology
Websitexspraypharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
2.47M
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
256.00K
1.39M
2.10M
2.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.44M
32.53M
30.01M
36.74M
Operating expense
44.69M
33.66M
32.10M
39.18M
Total operating expenses
44.69M
33.66M
32.10M
39.18M
Operating income
-44.69M
-31.20M
-32.10M
-39.18M
Other non operating income
-1.00K
-
-
-1.00K
EBT including unusual items
-47.33M
-37.01M
-35.38M
-39.80M
EBT excluding unusual items
-47.33M
-37.01M
-35.38M
-39.80M
Income tax expense
-25.00K
-21.00K
-18.00K
-14.00K
Effective tax rate
0.05%
0.06%
0.05%
0.04%
Other operating expenses
-
-253.00K
-
-
Net income
-47.31M
-36.99M
-35.36M
-39.78M
Net profit margin
-
-1,499.92%
-
-
Earnings per share
-1.25
-0.89
-
-
Interest and investment income
326.00K
679.00K
516.00K
499.00K
Interest expense
-5.01M
-4.30M
-4.23M
-9.26M
Net interest expenses
-4.68M
-3.62M
-3.71M
-8.77M
Depreciation and amortization charges
-
-
-
-
EBITDA
-43.30M
-29.81M
-30.72M
-38.14M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps